5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.21▼ | 5.22▼ | 5.28▼ | 5.40▼ | 4.41▲ |
MA10 | 5.21▼ | 5.30▼ | 5.34▼ | 5.30▼ | 3.84▲ |
MA20 | 5.20▼ | 5.37▼ | 5.41▼ | 4.56▲ | 3.73▲ |
MA50 | 5.30▼ | 5.45▼ | 5.42▼ | 3.72▲ | 3.05▲ |
MA100 | 5.35▼ | 5.42▼ | 4.97▲ | 3.67▲ | N/A |
MA200 | 5.41▼ | 4.88▲ | 4.17▲ | 3.24▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | -0.018▼ | -0.034▼ | 0.048▲ | 0.157▲ |
RSI | 42.709▼ | 35.565▼ | 40.081▼ | 67.230▲ | 66.319▲ |
STOCH | 43.977 | 13.146▼ | 20.043 | 69.165 | 74.582 |
WILL %R | -50.000 | -86.567▼ | -89.655▼ | -34.667 | -21.196▲ |
CCI | -53.333 | -107.168▼ | -126.065▼ | 37.184 | 201.876▲ |
Tuesday, June 10, 2025 10:30 AM
Given the probability of trial success and current valuation, we rate the ATYR stock 'Hold' as risk and reward appear balanced at this time. Click to read more on ATYR stock.
|
Wednesday, June 04, 2025 05:00 AM
SAN DIEGO, June 04, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of ...
|
Tuesday, May 20, 2025 05:00 AM
SAN DIEGO, May 20, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 5.30 | 5.50 | 5.15 | 5.20 | 2,111,500 |
12/06/25 | 5.35 | 5.61 | 5.25 | 5.43 | 1,373,700 |
11/06/25 | 5.55 | 5.749 | 5.33 | 5.395 | 2,077,700 |
10/06/25 | 5.575 | 5.98 | 5.425 | 5.505 | 2,588,821 |
09/06/25 | 5.50 | 5.525 | 5.15 | 5.45 | 2,611,700 |
06/06/25 | 5.47 | 5.52 | 5.337 | 5.38 | 2,578,100 |
05/06/25 | 5.24 | 5.655 | 5.185 | 5.35 | 3,035,600 |
04/06/25 | 5.495 | 5.65 | 5.075 | 5.14 | 4,675,148 |
03/06/25 | 4.775 | 5.75 | 4.6701 | 5.39 | 5,777,944 |
02/06/25 | 4.515 | 4.83 | 4.365 | 4.75 | 2,453,778 |
|
|
||||
|
|
||||
|
|